Rituximab improves survival in mantle cell lymphoma

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2012年 / 73卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [41] Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma
    Borgerding, Andrea
    Hasenkamp, Justin
    Glass, Bertram
    Wulf, Gerald
    Truemper, Lorenz
    ANNALS OF HEMATOLOGY, 2010, 89 (03) : 283 - 289
  • [42] Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma
    Alinari, Lapo
    White, Valerie L.
    Earl, Christian T.
    Ryan, Timothy P.
    Johnston, Jeffrey S.
    Dalton, James T.
    Ferketich, Amy K.
    Lai, Raymond
    Lucas, David M.
    Porcu, Pierluigi
    Blum, Kristie A.
    Byrd, John C.
    Baiocchi, Robert A.
    MABS, 2009, 1 (01) : 31 - 40
  • [43] Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: A systematic review and meta-analysis
    Schulz, Holger
    Bohlius, Julia F.
    Trelle, Sven
    Skoetz, Nicole
    Reiser, Marcel
    Kober, Thilo
    Schwarzer, Guido
    Herold, Michael
    Dreyling, Martin
    Hallek, Michael
    Engert, Andreas
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (09): : 706 - 714
  • [44] Nonpolypoid Intestinal Mantle Cell Lymphoma Resembling MALT Lymphoma with Successful Response to Rituximab
    D'Antonio, Antonio
    Boscaino, Amedeo
    Addesso, Maria
    Liguori, Giuseppina
    Nappi, Oscar
    SOUTHERN MEDICAL JOURNAL, 2008, 101 (11) : 1168 - 1169
  • [45] RITUXIMAB MAINTENANCE THERAPY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION PROLONGS PROGRESSION FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA
    Dietrich, S.
    Weidle, J.
    Meissner, J.
    Radujkovic, A.
    Ho, A.
    Dreger, P.
    Witzens-Harig, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S180 - S181
  • [46] Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation Prolongs Progression Free Survival In Patients With Mantle Cell Lymphoma
    Dietrich, Sascha
    Weidle, Julia
    Meissner, Julia
    Radujkovic, Aleksandar
    Ho, Anthony D.
    Dreger, Peter
    Witzens-Harig, Mathias
    BLOOD, 2013, 122 (21)
  • [47] Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma
    Merryman, Reid W.
    Edwin, Natasha
    Redd, Robert
    Bsat, Jad
    Chase, Matthew
    LaCasce, Ann
    Freedman, Arnold
    Jacobson, Caron
    Fisher, David
    Ng, Samuel
    Crombie, Jennifer
    Kim, Austin
    Odejide, Oreofe
    Davids, Matthew S.
    Brown, Jennifer R.
    Jacene, Heather
    Cashen, Amanda
    Bartlett, Nancy L.
    Mehta-Shah, Neha
    Ghobadi, Armin
    Kahl, Brad
    Joyce, Robin
    Armand, Philippe
    Jacobsen, Eric
    BLOOD ADVANCES, 2020, 4 (05) : 858 - 867
  • [48] Updated analysis of thalidomide plus rituximab in relapsed mantle cell lymphoma
    Drach, J
    Kaufmann, H
    Seidl, S
    Woehrer, S
    Chott, A
    Zielinski, C
    Raderer, M
    ANNALS OF ONCOLOGY, 2005, 16 : 137 - 137
  • [49] Factors predictive for response of follicular and mantle-cell lymphoma to rituximab
    Michael Pfreundschuh
    Nature Clinical Practice Oncology, 2006, 3 : 184 - 185
  • [50] Cladribine plus rituximab for the initial treatment of mantle cell lymphoma.
    Pindyck, T.
    Spurgeon, S. E.
    Okada, C. Y.
    Epner, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345